RayStation 12A
by RaySearch Laboratories AB (PUBL)
510(k) K222312
RayStation 12A is a medical device (FDA Class II; FDA product code MUJ, System, Planning, Radiation Therapy Treatment) made by RaySearch Laboratories AB (PUBL), cleared under FDA 510(k) K222312 on 29 Mar 2023, active as of 22 Oct 2026. 6 FDA recalls are linked to it.
Active
Valid until
No expiry
FDA recalls
6 ongoingDocuments
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK222312 | Date29 Mar 2023 | StatusActive |
Official records
- FDA 510(k) database K222312
From the FDA record
- Received by the FDA
- 1 Aug 2022
- FDA decision
- 29 Mar 2023 (Substantially Equivalent)
- FDA review time
- 240 days from receipt to decision
- Public document
- 510(k) summary on file with the FDA
Recalls
-
- Ongoing Z-1105-2026
Potential for the invalidation for calculated radiation dose does not work as intended for certain Regions of Interest (ROIs). This issue occurs for some ROI(s) which have no contours and either have a material override defined, or are of type Bolus, Fixation, or Support. In these cases, adding geometry to the ROI, subsequently modifying geometry, or removing the material override does not invalidate dose as intended.
-
- Ongoing Z-2493-2025
DICOM SOP Instance UID and Series Instance UID from RayGateway, i.e. the interface to Accuray's iDMS, are not guaranteed to be unique.
-
- Ongoing Z-1191-2025
Inconsistency in the use of Density uncertainty in the RayStation functions Robust optimization, Robust evaluation and Compute perturbed dose for proton and light ion treatment plans when a HU-to-mass density CT calibration curve used in RayStation version 4.5 to 2024B including some service packs.
-
- Ongoing Z-1750-2024
- Ongoing Z-1751-2024
Potential for reported SSD to be too high.
-
- Ongoing Z-1482-2024
A use error that has occurred with RayStation/RayPlan, where material override using Silicon, Si, was incorrectly selected for a silicone gel polymer implant.
Timeline
- Cleared FDA 510(k) K222312
- Recall initiated FDA recalls Z-1482-2024
- Recall initiated FDA recalls Z-1750-2024
- Recall initiated FDA recalls Z-1751-2024
- Recall initiated FDA recalls Z-1191-2025
- Recall initiated FDA recalls Z-2493-2025
- Recall initiated FDA recalls Z-1105-2026
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- MUJ
- Device class
- Class II
- Regulation
- 21 CFR Part 892.5050
- Advisory committee
- Radiology
- FDA decision
- SESE Substantially Equivalent
Devices cleared under K222312
Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.
| UDI-DI | Size and differences | |||
|---|---|---|---|---|
| RayStation 12A | 12A | 07350002010549 | On the market | |
| RayStation 12A SP1 | 12A SP1 | 07350002010679 | On the market | |
| RayStation 12A SP2 | 12A SP2 | 07350002010730 | On the market | |
| RayStation 2023B | 2023B | 07350002010556 | On the market |
Similar devices
Other devices filed under FDA product code MUJ (System, Planning, Radiation Therapy Treatment).
- RAYSTATION by Raysearch Laboratories AB
- ACQPLAN 5.0 by Philips Medical Systems
- RAY STATION by Raysearch Laboratories AB
- MONACO by Impac Medical Systems, Inc.
- MRCAT by Philips Medical Systems MR Finland
- HI-ART SYSTEM by Tomotherapy Incorporated
- STRATA, MODEL V.O.95 by Rosses Medical Systems
- FOCUS by Computerized Medical Systems, Inc.
- RT ELEMENTS, DOSE REVIEW, BRAIN METASTASES, ADAPTIVE HYBRID SURGERY ANALYSIS by Brainlab AG
- ART-Plan V2.X by Therapanacea Sas